CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale President & CEO sold 243,352 shares at an average $17.31 ($4,211,292)
- 4 Open-market sale Chief Financial Officer sold 161,940 shares at an average $17.19 ($2,784,219)
- 4 Option exercise Chief Operating Officer acquired 36,100 shares (option exercise)
- 8-K Event Other events
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Operating Officer sold 237,805 shares at an average $15.17 ($3,608,317)
- SC 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,079 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 64,338 shares (to pay taxes)
Page 13 of 33 · 652 filings